Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration

NCT ID: NCT00881023

Last Updated: 2016-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Cartilage Autograft Implantation System (CAIS) is designed as a single surgical treatment of damaged knee cartilage using the subject's own healthy cartilage obtained from a non-weight or low weight-bearing region. CAIS is indicated for the repair of articular cartilage lesions and osteochondritis dissecans (OCD) of the knee through cartilage regeneration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Cartilage Autograft Implantation System (CAIS) is a kit of devices that utilizes morselized autologous hyaline cartilage harvested arthroscopically, affixed onto a synthetic, resorbable implant using a fibrin sealant and implanted in a single surgical procedure. The system is designed as a surgical treatment of damaged knee cartilage using the subject's own healthy cartilage obtained from a non-weight or low weight-bearing region.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Defect of Articular Cartilage Osteochondritis Dissecans

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Randomized to Microfracture

Group Type ACTIVE_COMPARATOR

Microfracture

Intervention Type PROCEDURE

The microfracture procedure is a standard method for treatment of cartilage damage in which the surgeon will clean the site of your cartilage damage and then will make several small holes in your bone to stimulate your bone marrow with the intention to repair the damaged area with new cartilage tissue

2

Randomized to Device

Group Type EXPERIMENTAL

Cartilage Autograft Implantation System

Intervention Type DEVICE

A surgical treatment of damaged knee cartilage using the subject's own healthy cartilage obtained from a non-weight or low weight-bearing region

3

Non-randomized with lesion greater than 6cmˆ2

Group Type EXPERIMENTAL

Cartilage Autograft Implantation System

Intervention Type DEVICE

A surgical treatment of damaged knee cartilage using the subject's own healthy cartilage obtained from a non-weight or low weight-bearing region

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Microfracture

The microfracture procedure is a standard method for treatment of cartilage damage in which the surgeon will clean the site of your cartilage damage and then will make several small holes in your bone to stimulate your bone marrow with the intention to repair the damaged area with new cartilage tissue

Intervention Type PROCEDURE

Cartilage Autograft Implantation System

A surgical treatment of damaged knee cartilage using the subject's own healthy cartilage obtained from a non-weight or low weight-bearing region

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A male or female 18 to 55 years of age,
* Has 1 or 2 focal chondral lesions, that require repair, per index knee presenting with moderate to severe knee pain. Each lesion is ≤6 mm in depth and has an area of ≥1 cm2 and ≤10 cm2. Arthroscopic confirmation indicates that the lesions are either a non-OCD lesion between grades I and III (D) or an OCD lesion between grades I and IV(A)
* Prior failed chondral treatment is allowed if the procedure occurred \> 6 months for debridement and lavage or \> 1 year for marrow stimulation techniques.

Exclusion Criteria

* Have more than 2 chondral lesions on the index knee,
* Bipolar lesions on the index knee,
* Greater than 5 degrees of malalignment,
* Require bilateral surgery
* Have a diagnosis of clinical and/or radiographic disease of the index joint.
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

DePuy Mitek

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brooks Story, PhD

Role: STUDY_DIRECTOR

DePuy Synthes Mitek Sports Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tucson Orthopaedic Institute

Tucson, Arizona, United States

Site Status

MWMC Bentonville Hospital

Bentonville, Arkansas, United States

Site Status

CORE Orthopaedic Medical Center

Encinitas, California, United States

Site Status

Santa Monica Orthopaedic Group

Santa Monica, California, United States

Site Status

Southern California Orthopaedic Group

Van Nuys, California, United States

Site Status

JDP Medical Research, LLC

Denver, Colorado, United States

Site Status

Shrock Orthopedic Research

Fort Lauderdale, Florida, United States

Site Status

Andrews Institute

Gulf Breeze, Florida, United States

Site Status

Florida Orthopaedics Institute and Research Foundation

Tampa, Florida, United States

Site Status

Rush University Medical Center

Chicago, Illinois, United States

Site Status

OrthoIndy

Indianapolis, Indiana, United States

Site Status

University of Kentucky Medical Center

Lexington, Kentucky, United States

Site Status

Harvard Vanguard / New England Baptist Hospital

Chestnut Hill, Massachusetts, United States

Site Status

UMass Medical Center - Orthopedic Research

Worcester, Massachusetts, United States

Site Status

TRIA Orthopaedic Center

Bloomington, Minnesota, United States

Site Status

University of Missouri

Columbia, Missouri, United States

Site Status

Rothman Institute

Egg Harbor, New Jersey, United States

Site Status

University Orthopaedic Group LLC

New Brunswick, New Jersey, United States

Site Status

New York University School of Medicine

New York, New York, United States

Site Status

University of Rochester Medical Center

Rochester, New York, United States

Site Status

Orlin & Cohen Orthopedic Group

Rockville Centre, New York, United States

Site Status

Ohio State University

Columbus, Ohio, United States

Site Status

Orthopaedic Research Foundation of the Carolinas

Greenville, South Carolina, United States

Site Status

OrthoMemphis, PC

Memphis, Tennessee, United States

Site Status

Basin Orthopedic Surgical Specialists

Odessa, Texas, United States

Site Status

Richmond Bone & Joint Clinic, P.A.

Sugar Land, Texas, United States

Site Status

University of Virginia

Charlottesville, Virginia, United States

Site Status

Royal Columbian Hospital

New West Minster, British Columbia, Canada

Site Status

Fowler Kennedy Sports Medicine Clinic

New West Minister, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IDE # 11803

Identifier Type: OTHER

Identifier Source: secondary_id

08-CAIS-05

Identifier Type: -

Identifier Source: org_study_id

NCT00595803

Identifier Type: -

Identifier Source: nct_alias

NCT01508442

Identifier Type: -

Identifier Source: nct_alias

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.